BG
COLL icon

BlackRock Group’s Collegium Pharmaceutical COLL Stock Holding History

BlackRock Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$44K Buy
+2,839
New +$47.2K ﹤0.01% 2921

Other funds holding COLL

SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock Group's COLL Position: Q4 2016 in Review

BlackRock Group opened a new position in Collegium Pharmaceutical (COLL) in Q4 2016: 2,839 shares worth $44K. The stake represents ﹤0.01% of the portfolio and ranks #2921 among its holdings.

88 funds tracked by Wall St. Rank hold COLL as of Q4 2016.

  • BlackRock Group held 2,839 shares of Collegium Pharmaceutical worth $44K as of Q4 2016.
  • Collegium Pharmaceutical was a new BlackRock Group position in Q4 2016.
  • Collegium Pharmaceutical made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2921 holding.
  • 88 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.